TUESDAY, Sept. 4, 2018 — Nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the United States in 2017, marking a fourth consecutive year of sharp increases in these sexually transmitted diseases (STDs), according to a report published by the U.S. Centers for Disease Control and Prevention. Based on preliminary data for […]Continue Reading ...
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance. BUSM researchers (in collaboration with University of Toronto researchers) have been investigating the use of animal models of gonorrhea, to study how the infection evolves and for potential use to determine the efficacy […]Continue Reading ...
July 27, 2018 Critical Discovery Comes as Antibiotic-Resistant ‘Super Gonorrhea’ Spreads Good news in the battle against the growing threat of drug-resistant “super gonorrhea”: Researchers at the University of Virginia School of Medicine and their collaborators in the United Kingdom have discovered a new way that the bacteria that cause gonorrhea resist the body’s immune […]Continue Reading ...
May 16, 2018 The first European-wide genomic survey of gonorrhea has mapped antibiotic resistance in this sexually transmitted disease throughout the continent. Researchers at The Centre for Genomic Pathogen Surveillance (CGPS), the Wellcome Sanger Institute, European Centre for Disease Control, and their collaborators also showed that using DNA sequencing data they could accurately determine antibiotic […]Continue Reading ...
March 30, 2018 Every year, more than 100 million people worldwide develop the sexually transmitted disease gonorrhea, with health consequences such as infertility, transmission of the disease to newborn babies, and increased risk of HIV infections. There has been a 63 percent rise in gonorrhea in Australia over the past five years. Gonorrhea is caused […]Continue Reading ...
Via Sally Robertson, BScJuly 11, 2017 A meningococcal team B vaccine has been discovered to supply defense in opposition to gonorrhea, file researchers. That is the primary time a vaccine has secure in opposition to the STD and it will open up a brand new pathway for vaccine building. Reasonable crimson white blood cells with […]Continue Reading ...
Might 24, 2017 Researchers from UCLA have advanced a laboratory examine that is helping physicians resolve which individuals with gonorrhea is also extra treatable with an antibiotic that has now not been really helpful since 2007 as a result of considerations that the resistance to the drug used to be rising. Gonorrhea has advanced expanding […]Continue Reading ...
Neisseria gonorrhea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhoea. Overall, the rates of resistance to cefixime, ceftriaxone and azithromycin […]Continue Reading ...
May 17, 2018 Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance program for sexually transmitted infections shows distribution of drug-resistant gonorrhea strains across Europe. The study results are […]Continue Reading ...
CARB Fact Sheet (February 15, 2018) Gonococcal Isolate Surveillance Project (GISP) Profiles 2015 (June 1, 2017) AR Investment Map This interactive tool shows CDC’s key investments to combat antibiotic resistance (AR), including resistant gonorrhea, across the nation. Blog by NCHHSTP Director: What Healthcare Providers Can Do to Slow Gonorrhea’s Growing Resistance to First-line Antibiotics Combating the […]Continue Reading ...
WEDNESDAY, April 4, 2018 — Americans should expect that a super-resistant form of gonorrhea like that found in the United Kingdom will soon reach these shores, health experts say. Earlier this year, doctors diagnosed a man in England with a case of gonorrhea that could not be cured with antibiotics commonly deployed against the sexually […]Continue Reading ...
A man from United Kingdom has acquired a gonorrhea infection with bacteria that is resistant to most antibiotics used commonly against it. The man has a regular sexual partner but picked up this superbug from a sexual encounter with a partner in south-east Asia earlier this year.Continue Reading ...
July 7, 2017 Stories from WHO, in keeping with the information accrued from 77 nations, unearths that antibiotic resistance of gonorrhea, a not unusual sexually transmitted an infection is making the illness a lot more difficult and from time to time inconceivable to regard. Dr Teodora Wi, Scientific Officer, Human Copy, at WHO mentioned: “The […]Continue Reading ...
July 7, 2017 Zoliflodacin, a unique first-in-class oral antibiotic and one of the most best therapies in building to handle the rapidly-growing risk of drug-resistant gonorrhea will input pivotal trials, because of a brand new partnership between the not-for-profit World Antibiotic Analysis and Construction Partnership (GARDP) and Entasis Therapeutics. The announcement comes because the International […]Continue Reading ...
- FDA targets 465 websites that sell potentially dangerous, unapproved drugs
- New approach may lead to better diagnostic techniques for autoimmune disorders
- Innovative computer software sheds new light on genetic processes underlying deadly diseases
- Juul Drawing Lots of Teen Followers on Twitter
- WHO says Zika risk low in Pacific ahead of Meghan visit
- A deeper look at ‘Reflecting Frankenstein’
- Breastfeeding can have protective affect against high blood pressure in women, confirms study
- Epigenetic modifications may contribute to Alzheimer’s Disease
- Volunteering for peer counseling programs benefits people with lupus
- Cancer treatment may undergo a paradigm shift to immunotherapy soon
- Study uncovers new mechanism of action in a first-line drug for diabetes
- New type of molecule shows early promise against treatment-resistant prostate cancer
- Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients
- Scientists grow functioning human neural networks in 3D from stem cells
- Using mushrooms as a prebiotic may help improve glucose regulation
- New ENT clinic treats children in Zimbabwe
- CUIMC Celebrates 2018-2019, Issue 2
- Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer
- Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage
- Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics